Actionnariat et activité des initiés pour DiaMedica Therapeutics Inc. (DMAC): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $6.63 |
| Capitalisation | $357M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-10 | Pauls Dietrich John | A-Award | 60,200 | |
| 2026-01-02 | Parsons James T. | A-Award | 10,095 | $85K |
| 2026-01-02 | Giuffre Randall Michael | A-Award | 6,175 | $52K |
| 2026-01-02 | Semba Charles Pauling | A-Award | 3,355 | $28K |
| 2025-11-25 | STAHLBERG JAN | P-Purchase | 73,099 | $627K |
| 2025-11-24 | STAHLBERG JAN | P-Purchase | 40,253 | $318K |
| 2025-11-21 | STAHLBERG JAN | P-Purchase | 208,872 | $1.5M |
| 2025-11-20 | STAHLBERG JAN | P-Purchase | 128,426 | $951K |
| 2025-11-19 | STAHLBERG JAN | P-Purchase | 240,352 | $1.7M |
| 2025-11-18 | STAHLBERG JAN | P-Purchase | 182,882 | $1.2M |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $1.7M | $1.4M | $16.8M | $3.9M | $7.4M | $4.7M | $4.7M | $4.5M | $3.0M | $15.6M |
| Placements à Court Terme | 0 | 0 | 0 | $4.0M | $20.1M | $40.4M | $28.8M | $48.4M | $41.1M | $44.2M |
| Créances | $51974 | $80000 | $646000 | $823000 | 0 | 0 | $82000 | $369000 | $236000 | $258000 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $1.9M | $1.5M | $18.0M | $8.8M | $27.9M | $45.4M | $33.8M | $53.7M | $44.6M | $60.6M |
| Immobilisations Corporelles | $19395 | $37000 | $96000 | $217000 | $174000 | $112000 | $560000 | $485000 | $427000 | $342000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $1.9M | $1.8M | $18.3M | $9.1M | $28.1M | $45.6M | $34.4M | $54.2M | $46.3M | $61.4M |
| Dettes Fournisseurs | $250000 | $513000 | $483000 | $182000 | $1.1M | $509000 | $734000 | $926000 | $940000 | $1.5M |
| Dette à Court Terme | 0 | 0 | 0 | $60000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $626966 | $1.0M | $1.3M | $1.3M | $2.0M | $1.5M | $2.2M | $2.8M | $5.4M | $5.1M |
| Dette à Long Terme | 0 | 0 | $18000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $626966 | $1.0M | $1.3M | $1.4M | $2.1M | $1.5M | $2.6M | $3.1M | $5.6M | $5.3M |
| Réserves | -$46.7M | -$40.2M | -$46.0M | -$56.6M | -$68.9M | -$82.5M | -$96.2M | -$115.6M | -$140.0M | -$172.8M |
| Capitaux Propres | $1.2M | $799000 | $17.0M | $7.6M | $26.0M | $44.0M | $31.8M | $51.1M | $40.7M | $56.1M |
| Dette Totale | $200459 | 0 | $23000 | $178000 | $118000 | $52000 | $469000 | $400000 | $340000 | $240000 |
| Dette Nette | -$1.5M | -$1.4M | -$16.8M | -$7.7M | -$27.4M | -$45.1M | -$33.0M | -$52.5M | -$43.8M | -$59.6M |
| Fonds de Roulement | $1.2M | $491000 | $16.7M | $7.5M | $25.9M | $43.9M | $31.7M | $50.9M | $39.2M | $55.5M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 6.72 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 37.95 |
Rentabilité
| Rentabilité des capitaux propres | -77.68% |
| Rentabilité du capital investi | -100.87% |
| Rentabilité des actifs | -83.42% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ALT · ANNX · DBVT · DRTS · DSGN · ENGN · GALT
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de DMAC: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions